Additional European Equity News

Ageas (AGS BB) - Announced new 3yr  strategy: Shareholder renumeration EUR +1.9bln; avg. EPS growth +6-8%. (Newswires)

AstraZeneca (AZN LN) – Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial. Survival results for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in TROPION-Breast01 did not achieve statistical significance versus chemotherapy. (AstraZeneca)

Fortum (FORTUM FH) – Co. to sell its stake in the Biobased solutions business in India. (Newswires) 

Grifols (GRF SM) - BoD resolved that Mr Thomas Glanzmann becomes non-exec chairman. (Newswires) 

TotalEnergies (TTE FP) – Air France (AF FP) upgrades its sustainably aviation fuel purchasing deal with the Co.; TotalEnergies to supply up to 1.5mln tons of more sustainably aviation fuel to Air France over a 10yr period. (Newswires)

Skanksa (SKAB SS) – Selected for reservoir construction project in US for SEK 6.6bln. (Newswires)

Volkswagen (VOW3 GY) - According to Manager Magazin on Friday, citing dpa, suggested Volkswagen Group could cut up to 30,000 jobs out of 130,000 in Germany in the medium term, although the company did not confirm this figure. (Manager Magazin)

23 Sep 2024 - 07:07- EquitiesResearch Sheet- Source: Newsquawk